Philadelphia—2017 was a bumpy ride, and 2018 will be more of the same for pharmacists and all the stakeholders trying to get medications into the hands of patients, experts predicted at the recent Life Sciences Trade and Channel Strategies meeting. Many of the issues that began in 2017 have rolled into 2018; new sources of competition, vertical mergers and aquisition, 340B changes, Dipsy Doodle drug pricing and Amazon’s foray into health care are still challenges.